HSCT: Clinical Trials

5 trials for HSCT, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting, 2 recruiting, 1 enrolling by invitation. 5 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Not yet recruiting 2, Recruiting 2, Enrolling by invitation 1
Phase 24Not yet recruiting 2, Enrolling by invitation 1, Recruiting 1

Follow HSCT: new trials by email Literature Review of HSCT trials Research Report on HSCT

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Salvage Chemotherapy With Sonrotoclax, Cladribine, and Standard-dose Cytarabine, Sequentially Followed by HSCT for R/R AML.
Sonrotoclax, cladribine, and standard-dose cytarabine - AML (Acute Myelogenous Leukemia, HSCT
Phase 1 / Phase 2Not yet recruitingInstitute of Hematology & Blood Diseases Hospital, China502026-09-012026-08-11
Gecacitinib in the Treatment of Steroid-Refractory/Dependent Chronic Graf Versus Host Disease (cGVHD).
Gecacitinib - cGVHD, HSCT
Phase 1 / Phase 2Not yet recruitingInstitute of Hematology & Blood Diseases Hospital, China332026-03-162026-03-17
Romiplostim N01 for Platelet Recovery After Haploidentical HSCT
Romiplostim N01, Standard Supportive Care - Acute Myeloid Leukemia, MDS (Myelodysplastic Syndrome)
Phase 1RecruitingFirst Affiliated Hospital of Zhejiang University1302025-06-012026-01-28
Assessing Pulmonary Changes in HSCT
Hyperpolarized 129 Xenon - HSCT, Respiratory
Phase 1 / Phase 2RecruitingChildren's Hospital Medical Center, Cincinnati5502024-07-242026-09-16
Technical Development of Xe MRI
Hyperpolarized 129 Xenon - HSCT, Lung Transplant Recipient
Phase 1 / Phase 2Enrolling by invitationChildren's Hospital Medical Center, Cincinnati5502024-01-012026-09-16

Narrower conditions

Leukemia, Myeloid, Acute (2)  ·  Anemia, Refractory, with Excess of Blasts (1)

Broader conditions

Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Leukemia (2)  ·  Leukemia, Myeloid (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Anemia (1)  ·  Anemia, Refractory (1)  ·  Bone Marrow Diseases (1)  ·  Myelodysplastic Syndromes (1)

Interventions

Cladribine (1)  ·  Cytarabine (1)

Sponsors

Children's Hospital Medical Center, Cincinnati (2)  ·  Institute of Hematology & Blood Diseases Hospital, China (2)  ·  First Affiliated Hospital of Zhejiang University (1)

Countries

United States (2)  ·  China (1)

Top investigators

Laura Walkup, PhD (1)